Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

NO_LONGER_AVAILABLE

Conditions studied: Infection, Precancerous/Nonmalignant Condition

In brief

RATIONALE: Collecting the T cells from a donor and transplanting them into a patient may be effective treatment for immunodeficiency syndrome and CMV infection. PURPOSE: This clinical trial is studying the emergency use of adoptive immunotherapy with CMV-specific T cells after donor bone marrow transplant of an infant with immunodeficiency syndrome and CMV infection.

Key facts

Study ID

NCT00547235

Run by

Fred Hutchinson Cancer Center

Starts

2007-09-01

Last updated by the study team

2010-08-24

Who can join

Age: any, up to 1. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.